Millennium Management’s BIND Therapeutics BIND Stock Holding History
Bought
Maintained
Sold
Millennium Management's BIND Position: Q3 2016 in Review
Millennium Management sold out of BIND Therapeutics (BIND) in Q3 2016, closing a stake of 32,451 shares — an estimated $13K sold.
Millennium Management first reported a position in BIND in Q4 2013 and held it in 9 quarters. The position peaked at $1.38M in Q1 2014. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.
- Millennium Management reported no remaining BIND Therapeutics position as of Q3 2016 after selling out during the quarter.
- Millennium Management sold 32,451 BIND Therapeutics shares in Q3 2016, an estimated $13K.
- Millennium Management first reported a position in BIND Therapeutics in Q4 2013 and held it in 9 quarters.
- Millennium Management's BIND Therapeutics position peaked at $1.38M in Q1 2014.
- 0 funds tracked by Wall St. Rank held BIND Therapeutics as of Q3 2016.
Based on Millennium Management's 13F filing for Q3 2016, filed 14 Nov 2016.